SEAGEN INC's ticker is SGEN and the CUSIP is 81181C104. A total of 488 filers reported holding SEAGEN INC in Q1 2021. The put-call ratio across all filers is 0.69 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $18,246 | +50.5% | 86 | +36.5% | 0.00% | +33.3% |
| Q2 2023 | $12,126 | -6.4% | 63 | -1.6% | 0.00% | 0.0% |
| Q1 2023 | $12,959 | +40.1% | 64 | -11.1% | 0.00% | +50.0% |
| Q4 2022 | $9,253 | -22.9% | 72 | -15.3% | 0.00% | -33.3% |
| Q3 2022 | $12,000 | -14.3% | 85 | +7.6% | 0.00% | -25.0% |
| Q2 2022 | $14,000 | +7.7% | 79 | -12.2% | 0.00% | +33.3% |
| Q1 2022 | $13,000 | -18.8% | 90 | -15.1% | 0.00% | -25.0% |
| Q4 2021 | $16,000 | -11.1% | 106 | +3.9% | 0.00% | -20.0% |
| Q3 2021 | $18,000 | +12.5% | 102 | +4.1% | 0.01% | +25.0% |
| Q2 2021 | $16,000 | +23.1% | 98 | +2.1% | 0.00% | 0.0% |
| Q1 2021 | $13,000 | -7.1% | 96 | +18.5% | 0.00% | 0.0% |
| Q4 2020 | $14,000 | – | 81 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 47,288,259 | $7,465,870,000 | 32.79% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 145,000 | $22,868,000 | 6.04% |
| Lagoda Investment Management, L.P. | 59,780 | $9,438,000 | 4.40% |
| Avidity Partners Management LP | 640,000 | $101,043,000 | 2.73% |
| PFM Health Sciences, LP | 482,985 | $76,254,000 | 2.39% |
| Boxer Capital, LLC | 400,000 | $63,152,000 | 2.23% |
| Redmile Group, LLC | 771,385 | $121,786,000 | 1.80% |
| Woodline Partners LP | 577,655 | $91,200,000 | 1.70% |
| Rhenman & Partners Asset Management AB | 157,925 | $24,933,000 | 1.69% |
| Parkman Healthcare Partners LLC | 45,176 | $7,132,000 | 1.56% |